Emerging issues related to COVID-19 vaccination in patients with cancer

Coronavirus disease 2019 (COVID-19) has resulted in millions of deaths globally. The pandemic has had a severe impact on oncology care and research. Patients with underlying cancer are more vulnerable to contracting COVID-19, and also have a more severe clinical course following the infection. The r...

Descripción completa

Detalles Bibliográficos
Autores principales: Saini, Kamal S., Martins-Branco, Diogo, Tagliamento, Marco, Vidal, Laura, Singh, Navneet, Punie, Kevin, Saini, Monika Lamba, Chico, Isagani, Curigliano, Giuseppe, de Azambuja, Evandro, Lambertini, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208766/
https://www.ncbi.nlm.nih.gov/pubmed/34137014
http://dx.doi.org/10.1007/s40487-021-00157-1
Descripción
Sumario:Coronavirus disease 2019 (COVID-19) has resulted in millions of deaths globally. The pandemic has had a severe impact on oncology care and research. Patients with underlying cancer are more vulnerable to contracting COVID-19, and also have a more severe clinical course following the infection. The rollout of COVID-19 vaccines in many parts of the world has raised hopes of controlling the pandemic. In this editorial, the authors outline key characteristics of the currently approved COVID-19 vaccines, provide a brief overview of key emerging issues such as vaccine-induced immune thrombotic thrombocytopenia and SARS-CoV-2 variants of concern, and review the available data related to the efficacy and side effects of vaccinating patients with cancer.

Ejemplares similares